---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-003438"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2026-01-23T23:59:59+00:00"
generated_at: "2026-05-16T08:37:48.250028+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# QHSLab repurchases $470K promissory note with 1.57M shares, extinguishing related-party debt

## Summary
- Repurchased and cancelled promissory note held by MedScience; outstanding principal and interest $470,529 as of Dec 31, 2025.
- Issued 1,568,432 shares of common stock as consideration; shares issued in private transaction exempt from registration.
- CEO Troy Grogan is minority shareholder of MedScience; received no personal distribution from transaction.
- Company states repurchase simplifies capital structure and eliminates related-party debt obligation.

## SEC filing metadata
- accession: 0001493152-26-003438
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2026-01-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/0001493152-26-003438-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-003438
- JSON: https://secwatch.observer/filing/0001493152-26-003438.json
- Plain text: https://secwatch.observer/filing/0001493152-26-003438.txt

## Key facts
- Material Agreements
  QHSLab, Inc. terminated Repurchase Agreement with MedScience Research Group, Inc..
  - Action: termination
  - Counterparty: MedScience Research Group, Inc.
  source text: QHSLab, Inc. (the “Company”) consummated a Note Repurchase Agreement (the “Repurchase Agreement”) with MedScience Research Group, Inc., a Florida corporation (“MedScience”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/0001493152-26-003438-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
